The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Marine Derived Drugs Market Research Report 2025
Synopsis
The global market for Marine Derived Drugs was valued at US$ 2770 million in the year 2024 and is projected to reach a revised size of US$ 4959 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Marine Derived Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marine Derived Drugs.
The Marine Derived Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Marine Derived Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Marine Derived Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Seattle Genetics
Eisai Co
Tekada
Pfizer
Pharma Mar
Johnson and Johnson
GSK
TerSera Therapeutics
Teva
Segment by Type
Mollusk
Sponge
Tunicate
Fish
Others
Segment by Application
Antitumor Drugs
Anti-Cardiovascular Drugs
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Marine Derived Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Marine Derived Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Marine Derived Drugs was valued at US$ 2770 million in the year 2024 and is projected to reach a revised size of US$ 4959 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Marine Derived Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marine Derived Drugs.
The Marine Derived Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Marine Derived Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Marine Derived Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Seattle Genetics
Eisai Co
Tekada
Pfizer
Pharma Mar
Johnson and Johnson
GSK
TerSera Therapeutics
Teva
Segment by Type
Mollusk
Sponge
Tunicate
Fish
Others
Segment by Application
Antitumor Drugs
Anti-Cardiovascular Drugs
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Marine Derived Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Marine Derived Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Marine Derived Drugs Market Overview
1.1 Product Definition
1.2 Marine Derived Drugs by Type
1.2.1 Global Marine Derived Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Mollusk
1.2.3 Sponge
1.2.4 Tunicate
1.2.5 Fish
1.2.6 Others
1.3 Marine Derived Drugs by Application
1.3.1 Global Marine Derived Drugs Market Value by Application (2024 VS 2031)
1.3.2 Antitumor Drugs
1.3.3 Anti-Cardiovascular Drugs
1.3.4 Others
1.4 Global Marine Derived Drugs Market Size Estimates and Forecasts
1.4.1 Global Marine Derived Drugs Revenue 2020-2031
1.4.2 Global Marine Derived Drugs Sales 2020-2031
1.4.3 Global Marine Derived Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Marine Derived Drugs Market Competition by Manufacturers
2.1 Global Marine Derived Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Marine Derived Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Marine Derived Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Marine Derived Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Marine Derived Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Marine Derived Drugs, Product Type & Application
2.7 Global Key Manufacturers of Marine Derived Drugs, Date of Enter into This Industry
2.8 Global Marine Derived Drugs Market Competitive Situation and Trends
2.8.1 Global Marine Derived Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Marine Derived Drugs Players Market Share by Revenue
2.8.3 Global Marine Derived Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Marine Derived Drugs Market Scenario by Region
3.1 Global Marine Derived Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Marine Derived Drugs Sales by Region: 2020-2031
3.2.1 Global Marine Derived Drugs Sales by Region: 2020-2025
3.2.2 Global Marine Derived Drugs Sales by Region: 2026-2031
3.3 Global Marine Derived Drugs Revenue by Region: 2020-2031
3.3.1 Global Marine Derived Drugs Revenue by Region: 2020-2025
3.3.2 Global Marine Derived Drugs Revenue by Region: 2026-2031
3.4 North America Marine Derived Drugs Market Facts & Figures by Country
3.4.1 North America Marine Derived Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Marine Derived Drugs Sales by Country (2020-2031)
3.4.3 North America Marine Derived Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Marine Derived Drugs Market Facts & Figures by Country
3.5.1 Europe Marine Derived Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Marine Derived Drugs Sales by Country (2020-2031)
3.5.3 Europe Marine Derived Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Marine Derived Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Marine Derived Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Marine Derived Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Marine Derived Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Marine Derived Drugs Market Facts & Figures by Country
3.7.1 Latin America Marine Derived Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Marine Derived Drugs Sales by Country (2020-2031)
3.7.3 Latin America Marine Derived Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Marine Derived Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Marine Derived Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Marine Derived Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Marine Derived Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Marine Derived Drugs Sales by Type (2020-2031)
4.1.1 Global Marine Derived Drugs Sales by Type (2020-2025)
4.1.2 Global Marine Derived Drugs Sales by Type (2026-2031)
4.1.3 Global Marine Derived Drugs Sales Market Share by Type (2020-2031)
4.2 Global Marine Derived Drugs Revenue by Type (2020-2031)
4.2.1 Global Marine Derived Drugs Revenue by Type (2020-2025)
4.2.2 Global Marine Derived Drugs Revenue by Type (2026-2031)
4.2.3 Global Marine Derived Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Marine Derived Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Marine Derived Drugs Sales by Application (2020-2031)
5.1.1 Global Marine Derived Drugs Sales by Application (2020-2025)
5.1.2 Global Marine Derived Drugs Sales by Application (2026-2031)
5.1.3 Global Marine Derived Drugs Sales Market Share by Application (2020-2031)
5.2 Global Marine Derived Drugs Revenue by Application (2020-2031)
5.2.1 Global Marine Derived Drugs Revenue by Application (2020-2025)
5.2.2 Global Marine Derived Drugs Revenue by Application (2026-2031)
5.2.3 Global Marine Derived Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Marine Derived Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Seattle Genetics
6.1.1 Seattle Genetics Company Information
6.1.2 Seattle Genetics Description and Business Overview
6.1.3 Seattle Genetics Marine Derived Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Seattle Genetics Marine Derived Drugs Product Portfolio
6.1.5 Seattle Genetics Recent Developments/Updates
6.2 Eisai Co
6.2.1 Eisai Co Company Information
6.2.2 Eisai Co Description and Business Overview
6.2.3 Eisai Co Marine Derived Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eisai Co Marine Derived Drugs Product Portfolio
6.2.5 Eisai Co Recent Developments/Updates
6.3 Tekada
6.3.1 Tekada Company Information
6.3.2 Tekada Description and Business Overview
6.3.3 Tekada Marine Derived Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Tekada Marine Derived Drugs Product Portfolio
6.3.5 Tekada Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Marine Derived Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Marine Derived Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Pharma Mar
6.5.1 Pharma Mar Company Information
6.5.2 Pharma Mar Description and Business Overview
6.5.3 Pharma Mar Marine Derived Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pharma Mar Marine Derived Drugs Product Portfolio
6.5.5 Pharma Mar Recent Developments/Updates
6.6 Johnson and Johnson
6.6.1 Johnson and Johnson Company Information
6.6.2 Johnson and Johnson Description and Business Overview
6.6.3 Johnson and Johnson Marine Derived Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson and Johnson Marine Derived Drugs Product Portfolio
6.6.5 Johnson and Johnson Recent Developments/Updates
6.7 GSK
6.7.1 GSK Company Information
6.7.2 GSK Description and Business Overview
6.7.3 GSK Marine Derived Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GSK Marine Derived Drugs Product Portfolio
6.7.5 GSK Recent Developments/Updates
6.8 TerSera Therapeutics
6.8.1 TerSera Therapeutics Company Information
6.8.2 TerSera Therapeutics Description and Business Overview
6.8.3 TerSera Therapeutics Marine Derived Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 TerSera Therapeutics Marine Derived Drugs Product Portfolio
6.8.5 TerSera Therapeutics Recent Developments/Updates
6.9 Teva
6.9.1 Teva Company Information
6.9.2 Teva Description and Business Overview
6.9.3 Teva Marine Derived Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva Marine Derived Drugs Product Portfolio
6.9.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Marine Derived Drugs Industry Chain Analysis
7.2 Marine Derived Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Marine Derived Drugs Production Mode & Process Analysis
7.4 Marine Derived Drugs Sales and Marketing
7.4.1 Marine Derived Drugs Sales Channels
7.4.2 Marine Derived Drugs Distributors
7.5 Marine Derived Drugs Customer Analysis
8 Marine Derived Drugs Market Dynamics
8.1 Marine Derived Drugs Industry Trends
8.2 Marine Derived Drugs Market Drivers
8.3 Marine Derived Drugs Market Challenges
8.4 Marine Derived Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Marine Derived Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Marine Derived Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Marine Derived Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Marine Derived Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Marine Derived Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Marine Derived Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Marine Derived Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Marine Derived Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Marine Derived Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Marine Derived Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Marine Derived Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Marine Derived Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Marine Derived Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Derived Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Marine Derived Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Marine Derived Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Marine Derived Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Marine Derived Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Marine Derived Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Marine Derived Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Marine Derived Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Marine Derived Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Marine Derived Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Marine Derived Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Marine Derived Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Marine Derived Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Marine Derived Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Marine Derived Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Marine Derived Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Marine Derived Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Marine Derived Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Marine Derived Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Marine Derived Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Marine Derived Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Marine Derived Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Marine Derived Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Marine Derived Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Marine Derived Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Marine Derived Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Marine Derived Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Marine Derived Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Marine Derived Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Marine Derived Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Marine Derived Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Marine Derived Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Marine Derived Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Marine Derived Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Marine Derived Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Marine Derived Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Marine Derived Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Marine Derived Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Marine Derived Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Marine Derived Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Marine Derived Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Marine Derived Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Marine Derived Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Marine Derived Drugs Price (USD/Unit) by Type (2020-2025)
Table 59. Global Marine Derived Drugs Price (USD/Unit) by Type (2026-2031)
Table 60. Global Marine Derived Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Marine Derived Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Marine Derived Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Marine Derived Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Marine Derived Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Marine Derived Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Marine Derived Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Marine Derived Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Marine Derived Drugs Price (USD/Unit) by Application (2020-2025)
Table 69. Global Marine Derived Drugs Price (USD/Unit) by Application (2026-2031)
Table 70. Seattle Genetics Company Information
Table 71. Seattle Genetics Description and Business Overview
Table 72. Seattle Genetics Marine Derived Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Seattle Genetics Marine Derived Drugs Product
Table 74. Seattle Genetics Recent Developments/Updates
Table 75. Eisai Co Company Information
Table 76. Eisai Co Description and Business Overview
Table 77. Eisai Co Marine Derived Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Eisai Co Marine Derived Drugs Product
Table 79. Eisai Co Recent Developments/Updates
Table 80. Tekada Company Information
Table 81. Tekada Description and Business Overview
Table 82. Tekada Marine Derived Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Tekada Marine Derived Drugs Product
Table 84. Tekada Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Marine Derived Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Marine Derived Drugs Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Pharma Mar Company Information
Table 91. Pharma Mar Description and Business Overview
Table 92. Pharma Mar Marine Derived Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Pharma Mar Marine Derived Drugs Product
Table 94. Pharma Mar Recent Developments/Updates
Table 95. Johnson and Johnson Company Information
Table 96. Johnson and Johnson Description and Business Overview
Table 97. Johnson and Johnson Marine Derived Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Johnson and Johnson Marine Derived Drugs Product
Table 99. Johnson and Johnson Recent Developments/Updates
Table 100. GSK Company Information
Table 101. GSK Description and Business Overview
Table 102. GSK Marine Derived Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. GSK Marine Derived Drugs Product
Table 104. GSK Recent Developments/Updates
Table 105. TerSera Therapeutics Company Information
Table 106. TerSera Therapeutics Description and Business Overview
Table 107. TerSera Therapeutics Marine Derived Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. TerSera Therapeutics Marine Derived Drugs Product
Table 109. TerSera Therapeutics Recent Developments/Updates
Table 110. Teva Company Information
Table 111. Teva Description and Business Overview
Table 112. Teva Marine Derived Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Teva Marine Derived Drugs Product
Table 114. Teva Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Marine Derived Drugs Distributors List
Table 118. Marine Derived Drugs Customers List
Table 119. Marine Derived Drugs Market Trends
Table 120. Marine Derived Drugs Market Drivers
Table 121. Marine Derived Drugs Market Challenges
Table 122. Marine Derived Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Marine Derived Drugs
Figure 2. Global Marine Derived Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Marine Derived Drugs Market Share by Type: 2024 & 2031
Figure 4. Mollusk Product Picture
Figure 5. Sponge Product Picture
Figure 6. Tunicate Product Picture
Figure 7. Fish Product Picture
Figure 8. Others Product Picture
Figure 9. Global Marine Derived Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Marine Derived Drugs Market Share by Application: 2024 & 2031
Figure 11. Antitumor Drugs
Figure 12. Anti-Cardiovascular Drugs
Figure 13. Others
Figure 14. Global Marine Derived Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Marine Derived Drugs Market Size (2020-2031) & (US$ Million)
Figure 16. Global Marine Derived Drugs Sales (2020-2031) & (K Units)
Figure 17. Global Marine Derived Drugs Average Price (USD/Unit) & (2020-2031)
Figure 18. Marine Derived Drugs Report Years Considered
Figure 19. Marine Derived Drugs Sales Share by Manufacturers in 2024
Figure 20. Global Marine Derived Drugs Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Marine Derived Drugs Players: Market Share by Revenue in Marine Derived Drugs in 2024
Figure 22. Marine Derived Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Marine Derived Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Marine Derived Drugs Sales Market Share by Country (2020-2031)
Figure 25. North America Marine Derived Drugs Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Marine Derived Drugs Sales Market Share by Country (2020-2031)
Figure 29. Europe Marine Derived Drugs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Marine Derived Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Marine Derived Drugs Revenue Market Share by Region (2020-2031)
Figure 37. China Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Taiwan Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Marine Derived Drugs Sales Market Share by Country (2020-2031)
Figure 48. Latin America Marine Derived Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Marine Derived Drugs Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Marine Derived Drugs Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Marine Derived Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Marine Derived Drugs by Type (2020-2031)
Figure 58. Global Revenue Market Share of Marine Derived Drugs by Type (2020-2031)
Figure 59. Global Marine Derived Drugs Price (USD/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Marine Derived Drugs by Application (2020-2031)
Figure 61. Global Revenue Market Share of Marine Derived Drugs by Application (2020-2031)
Figure 62. Global Marine Derived Drugs Price (USD/Unit) by Application (2020-2031)
Figure 63. Marine Derived Drugs Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
